Short answer
Enliven Therapeutics, Inc. (ELVN) filed an 8-K current report with the SEC on October 14, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Board expanded from seven to eight directors, adding Kristine Ball as a Class II director through the 2028 annual meeting.
Enliven Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from seven to eight directors, adding Kristine Ball as a Class II director through the 2028 annual meeting
- Ball joins the Audit Committee, strengthening board-level financial oversight
- Annual compensation totals $55,000, including $45,000 as director and $10,000 for Audit Committee service
- Stock options granted with approximately $650,000 fair value, vesting monthly over 36 months
- Full option acceleration upon a change in control, increasing potential transaction-related dilution for shareholders
Item 7.01 · Regulation FD Disclosure
- Board appointment of Ms. Ball announced October 14, 2026
- Leadership addition may influence governance and strategic oversight
- Exhibit 99.1 contains the appointment press release
Item EX-99.1 · Exhibit EX-99.1
- Kristine Ball appointed to Enliven’s board, adding biotechnology expertise in finance, strategy, governance and commercial readiness
- Appointment supports planned transition from clinical development toward commercialization
- Pivotal ENABLE-2 Phase 3 trial of relcobatinib planned before year-end 2026
- FDA alignment on ENABLE-2’s final design reduces a key trial-planning uncertainty
- Key risks remain trial delays, inadequate efficacy or safety, regulatory setbacks and additional capital requirements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Enliven Therapeutics, Inc. 8-K filings
Get the next ELVN 8-K as it lands
Follow ELVN for push alerts, or ask the research agent what this filing means.